Recently, it has also been reported that IL-6 is an important mediator of the tumor-promoting effect of inflammation-related diseases, and that patients with advanced or metastatic colon cancer have elevated serum IL-6 levels [29]. This evidence concerns the gene IL6 and neoplasm.